-+ 0.00%
-+ 0.00%
-+ 0.00%

Tyra Biosciences Announces Promising Preclinical Results for TYRA-300 in FGFR3-related Skeletal Dysplasia at ENDO 2025

Reuters·07/08/2025 20:05:40

Please log in to view news